Aripiprazole Augmentation in Patients with Resistant Obsessive Compulsive Disorder: a Pilot Study

BACKGROUND: Antipsychotic augmentation is an effective treatment intervention for Obsessive Compulsive Disorder (OCD) patients resistant to Selective Serotonin Reuptake Inhibitors (SSRI) agents. This pilot study was conducted to evaluate the effectiveness and tolerability of Aripiprazole for the aug...

Descripción completa

Detalles Bibliográficos
Autores principales: Delle Chiaie, Roberto, Scarciglia, Pierluigi, Pasquini, Massimo, Caredda, Maria, Biondi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115673/
https://www.ncbi.nlm.nih.gov/pubmed/21686322
http://dx.doi.org/10.2174/1745017901107010107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115673/
https://www.ncbi.nlm.nih.gov/pubmed/21686322
http://dx.doi.org/10.2174/1745017901107010107

Ejemplares similares